Related Experiment Videos
Penile metastases from urogenital primaries
K Matuszewska1, M Matuszewski, A Kowalczyk
1Department of Oncology and Radiotherapy; Medical University of Gdansk, Gdansk, 80-952 Poland. akow@amedec.amg.gda.pl
Neoplasma
|November 30, 2002
Summary
Metastatic tumors of the penis are rare, often originating from genitourinary or gastrointestinal cancers. Treatment focuses on palliation, but the prognosis for penile metastases remains poor due to advanced disease.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Metastatic tumors to the penis are uncommon, typically arising from primary cancers within the genitourinary or gastrointestinal systems.
- These secondary penile malignancies present with severe symptoms, necessitating prompt medical attention.
Observation:
- Common presenting symptoms include dysuria, penile pain, induration, swelling, and priapism.
- The presence of these symptoms indicates advanced disease and the need for immediate intervention.
Findings:
- Treatment modalities for penile metastases are primarily palliative, including surgical excision, amputation, radiotherapy, and chemotherapy.
- Despite interventions, the overall prognosis for patients with metastatic penile cancer is poor.
Implications:
- The advanced stage at diagnosis significantly impacts treatment outcomes and patient survival.
- Further research may explore earlier detection methods and more effective therapeutic strategies for metastatic penile disease.